Shinva Medical InstrumentLtd Toekomstige groei

Future criteriumcontroles 2/6

Shinva Medical InstrumentLtd zal naar verwachting groeien in winst en omzet met respectievelijk 21.5% en 11% per jaar. De winst per aandeel zal naar verwachting groeien met 19% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 11.5% zijn.

Belangrijke informatie

21.5%

Groei van de winst

19.0%

Groei van de winst per aandeel

Medical Equipment winstgroei	27.3%
Inkomstengroei	11.0%
Toekomstig rendement op eigen vermogen	11.5%
Dekking van analisten	Low
Laatst bijgewerkt	02 Sep 2024

Recente toekomstige groei-updates

Recent updates

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Jul 18

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Jun 07

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Apr 22

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Mar 28

Winst- en omzetgroeiprognoses

SHSE:600587 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	13,153	1,164	N/A	1,760	3
12/31/2025	11,979	976	N/A	1,394	3
12/31/2024	10,915	817	N/A	659	3
9/30/2024	10,118	692	329	706	N/A
6/30/2024	10,125	680	425	865	N/A
3/31/2024	10,102	669	281	800	N/A
12/31/2023	10,012	654	494	1,030	N/A
9/30/2023	9,948	659	179	730	N/A
6/30/2023	9,919	636	321	757	N/A
3/31/2023	9,608	569	434	757	N/A
12/31/2022	9,282	500	140	388	N/A
9/30/2022	8,778	539	-205	63	N/A
6/30/2022	8,457	550	-37	216	N/A
3/31/2022	9,078	538	465	720	N/A
12/31/2021	9,482	556	1,128	1,403	N/A
9/30/2021	9,974	459	1,571	1,750	N/A
6/30/2021	10,591	435	1,639	1,866	N/A
3/31/2021	9,938	347	1,221	1,429	N/A
12/31/2020	9,151	234	907	1,098	N/A
9/30/2020	8,983	272	722	823	N/A
6/30/2020	8,616	297	602	705	N/A
3/31/2020	8,470	333	360	527	N/A
12/31/2019	8,767	861	415	631	N/A
9/30/2019	9,347	671	258	922	N/A
6/30/2019	9,814	659	328	940	N/A
3/31/2019	10,135	556	418	1,111	N/A
12/31/2018	10,284	23	-73	653	N/A
9/30/2018	10,144	207	346	860	N/A
6/30/2018	10,116	38	N/A	741	N/A
3/31/2018	10,051	50	N/A	664	N/A
12/31/2017	9,983	66	N/A	959	N/A
9/30/2017	9,551	-100	N/A	554	N/A
6/30/2017	9,091	25	N/A	523	N/A
3/31/2017	8,696	36	N/A	523	N/A
12/31/2016	8,364	35	N/A	189	N/A
9/30/2016	8,139	223	N/A	210	N/A
6/30/2016	7,895	236	N/A	235	N/A
3/31/2016	7,686	244	N/A	-125	N/A
12/31/2015	7,554	281	N/A	110	N/A
9/30/2015	7,256	291	N/A	-110	N/A
6/30/2015	7,000	308	N/A	-209	N/A
3/31/2015	6,749	320	N/A	-76	N/A
12/31/2014	6,283	326	N/A	52	N/A
9/30/2014	5,613	303	N/A	-19	N/A
6/30/2014	4,999	280	N/A	-29	N/A
3/31/2014	4,476	265	N/A	5	N/A
12/31/2013	4,194	232	N/A	22	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei 600587 ( 21.5% per jaar) ligt boven de spaarquote ( 2.9% ).

Winst versus markt: De winst van 600587 ( 21.5% per jaar) zal naar verwachting langzamer groeien dan de markt CN ( 25.9% per jaar).

Hoge groeiwinsten: De winst van 600587 zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van 600587 ( 11% per jaar) zal naar verwachting langzamer groeien dan de markt CN ( 14% per jaar).

Hoge groei-inkomsten: De omzet van 600587 ( 11% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen 600587 zal naar verwachting over 3 jaar laag zijn ( 11.5 %).

Shinva Medical InstrumentLtd Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased to CN¥41.65

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.20 in 3Q 2023)

Now 23% undervalued

Estimating The Fair Value Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 20%

Returns At Shinva Medical InstrumentLtd (SHSE:600587) Are On The Way Up

Second quarter 2024 earnings released: EPS: CN¥0.74 (vs CN¥0.43 in 2Q 2023)

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Now 19% overvalued

Shinva Medical Instrument Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Now 22% overvalued

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Investor sentiment deteriorates as stock falls 17%

Dividend increased to CN¥0.50

First quarter 2024 earnings released: EPS: CN¥0.45 (vs CN¥0.46 in 1Q 2023)

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Full year 2023 earnings: EPS and revenues miss analyst expectations

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Investor sentiment deteriorates as stock falls 19%

Shinva Medical Instrument Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.24 in 3Q 2022)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.57 (vs CN¥0.48 in 2Q 2022)

New minor risk - Dividend sustainability

Full year 2022 earnings released: EPS: CN¥1.23 (vs CN¥1.37 in FY 2021)

Investor sentiment improves as stock rises 17%

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.27 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.48 (vs CN¥0.45 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to CN¥41.65

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.25 in 2Q 2020)

Investor sentiment improved over the past week

Zou Huiling acquired 16.67% stake in Beijing Huaco Healthcare Technologies Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 25 million.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.08 in 1Q 2020)

New 90-day low: CN¥12.23

New 90-day low: CN¥13.25

New 90-day low: CN¥14.41

New 90-day low: CN¥14.78

New 90-day low: CN¥15.88

Third quarter earnings released

Shinva Medical Instrument Co., Ltd. to Report Q3, 2020 Results on Oct 31, 2020

First half earnings released

Nanyang Great Health Medical Care Industry Development Co., Ltd acquired 80% stake in Nanyang Orthopedics High-tech Zone Hospital Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 53.8 million.

New 90-day high - CN¥18.41

Shinva Medical Instrument Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven